Zamuner, Stefano

Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies

Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., et al. (2013) · Journal of Psychopharmacology

Treatment of Major DepressionNeuropeptides and Animal Physiology

Cited by 69

Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target Occupancy

Abanades, S., van der Aart, J., Barletta, J. A., Marzano, C., Searle, G. E., Salinas, C. A., Ahmad, J. J., Reiley, R. R., Pampols-Maso, S., Zamuner, S., et al. (2011) · Journal of Cerebral Blood Flow & Metabolism

Pharmacogenetics and Drug MetabolismMedical Imaging Techniques and Applications

Cited by 61

Data-driven large-scale genomic analysis reveals an intricate phylogenetic and functional landscape in J-domain proteins

Malinverni, D., Zamuner, S., Rebeaud, M. E., Barducci, A., Nillegoda, N. B., & De Los Rios, P. (2022) · Proceedings of the National Academy of Sciences

Heat shock proteins researchGenomics and Phylogenetic Studies

Cited by 39

Data-driven large-scale genomic analysis reveals an intricate phylogenetic and functional landscape in J-domain proteins

Malinverni, D., Zamuner, S., Rebeaud, M. E., Barducci, A., Nillegoda, N. B., & De Los Rios, P. (2023) · Proceedings of the National Academy of Sciences

Heat shock proteins researchGenomics and Phylogenetic Studies

Cited by 39

Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis

Sahota, T., Berges, A., Barton, S., Cookson, L., Zamuner, S., & Richards, D. (2015) · CPT: Pharmacometrics & Systems Pharmacology

Amyloidosis: Diagnosis, Treatment, OutcomesPharmaceutical studies and practices

Cited by 19